Introduction
Material and methods
Study design and participant inclusion
Diagnostic imaging
Image analysis
Hip arthroscopy
Statistical analysis
Results
Patient characteristics
Image quality
Likert scale | Reader 1 | Reader 2 | ||||
---|---|---|---|---|---|---|
GBCA-MRA | Saline-MRA | p value | GBCA-MRA | Saline-MRA | p value | |
Labrum | 1.2 ± 0.5 | 1.2 ± 0.4 | 0.198 | 1.2 ± 0.5 | 1.3 ± 0.4 | 0.646 |
Acetabular cartilage | 1.3 ± 0.6 | 1.2 ± 0.4 | 0.853 | 1.2 ± 0.5 | 1.2 ± 0.4 | 0.952 |
Femoral cartilage | 1.1 ± 0.3 | 1.1 ± 0.3 | 0.882 | 1.2 ± 0.4 | 1.1 ± 0.3 | 0.419 |
Ligamentum teres | 1.2 ± 0.4 | 1.1 ± 0.3 | 0.183 | 1.1 ± 0.4 | 1.1 ± 0.3 | 0.216 |
Capsule | 1.3 ± 0.5 | 1.2 ± 0.5 | 0.782 | 1.2 ± 0.4 | 1.3 ± 0.5 | 0.400 |
Overall contrast | 1.1 ± 0.4 | 1.8 ± 0.5 | < 0.001 | 1.1 ± 0.3 | 1.9 ± 0.4 | 0.019 |
Diagnostic performance
Labrum | Acetabular cartilage | Femoral cartilage | Extensive cartilage damage > 2 h (60°) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
GBCA | Saline-MRA | p value | GBCA-MRA | Saline-MRA | p value | GBCA-MRA | Saline-MRA | p value | GBCA-MRA | Saline-MRA | p value | |
True positive (no. of hips) | 64/70 | 66/70 | - | 46/70 | 44/70 | - | 9/70 | 9/70 | - | 13/70 | 13/70 | - |
True negative (no. of hips) | 2/70 | 1/70 | - | 14/70 | 18/70 | - | 59/70 | 59/70 | - | 52/70 | 55/70 | - |
False positive (no of hips) | 4/70 | 2/70 | - | 2/70 | 1/70 | - | 2/70 | 1/70 | - | 2/70 | 2/70 | - |
False negative (no. of hips) | 0/70 | 1/70 | - | 8/70 | 7/70 | - | 0/70 | 1/70 | - | 3/70 | 0/70 | - |
Sensitivity (%) | 100 (94–100) | 99 (92–100) | > 0.999 | 85 (73–92) | 86 (74–93) | > 0.999 | 100 (70–100) | 90 (60–99) | > 0.999 | 81 (57–93) | 100 (77–100) | 0.790 |
Specificity (%) | 33 (6–70) | 33 (2–88) | > 0.999 | 88 (64–98) | 95 (75–100) | > 0.999 | 97 (89–99) | 98 (91–100) | > 0.999 | 96 (87–99) | 97 (88–99) | > 0.999 |
PPV (%) | 94 (86–98) | 97 (90–99) | 0.903 | 96 (86–99) | 98 (88–100) | > 0.999 | 82 (52–97) | 90 (60–99) | > 0.999 | 87 (62–98) | 87 (62–98) | > 0.999 |
NPV (%) | 100 (18–100) | 50 (3–97) | > 0.999 | 64 (43–80) | 72 (52–86) | 0.822 | 100 (94–100) | 98 (91–100) | > 0.999 | 95 (85–99) | 100 (94–100) | 0.892 |
Accuracy (%) | 94 (83–97) | 96 (88–99) | > 0.999 | 86 (75–93) | 89 (78–95) | 0.902 | 97 (90–100) | 97 (90–100) | > 0.999 | 93 (84–98) | 97 (90–100) | 0.904 |
Grading agreement MRI versus surgery (ĸ) | 0.58 (0.41–0.74) | 0.69 (0.53–0.86) | - | 0.63 (0.47–0.79) | 0.66 (0.51–0.82) | - | 0.86 (0.68–1.00) | 0.89 (0.74–1.00) | - | 0.79 (0.62–0.97) | 0.91 (0.79–1.00) | - |
Labrum | Acetabular cartilage | Femoral cartilage | Extensive cartilage damage > 2 h (60°) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
GBCA-MRA | Saline-MRA | p value | GBCA-MRA | Saline-MRA | p value | GBCA-MRA | Saline-MRA | p value | GBCA-MRA | Saline-MRA | p value | |
True positive (no. of hips) | 64/70 | 64/70 | - | 46/70 | 46/70 | - | 9/70 | 8/70 | - | 14/70 | 12/70 | - |
True negative (no. of hips) | 3/70 | 1/70 | - | 12/70 | 15/70 | - | 60/70 | 60/70 | - | 54/70 | 55/70 | - |
False positive (no of hips) | 3/70 | 2/70 | - | 4/70 | 4/70 | - | 1/70 | 0/70 | - | 0/70 | 2/70 | - |
False negative (no. of hips) | 0/70 | 3/70 | - | 8/70 | 5/70 | - | 0/70 | 2/70 | - | 2/70 | 1/70 | - |
Sensitivity (%) | 100 (94–100) | 96 (88–99) | > 0.999 | 85 (73–92) | 90 (79–96) | 0.887 | 100 (71–100) | 80 (49–96) | > 0.999 | 88 (64–98) | 92 (67–100) | > 0.999 |
Specificity (%) | 50 (12–88) | 33 (2–88) | 0.571 | 75 (50–90) | 79 (57–92) | > 0.999 | 98 (91–100) | 100 (94–100) | > 0.999 | 100 (93–100) | 97 (88–99) | > 0.999 |
PPV (%) | 96 (91–98) | 97 (90–100) | > 0.999 | 92 (81–97) | 92 (81–97) | > 0.999 | 90 (60–100) | 100 (68–100) | > 0.999 | 100 (79–100) | 86 (60–98) | 0.793 |
NPV (%) | 100 (18–100) | 25 (1–70) | > 0.999 | 60 (39–78) | 75 (53–89) | 0.804 | 100 (94–100) | 97 (89–99) | > 0.999 | 96 (88–99) | 98 (91–100) | > 0.999 |
Accuracy (%) | 96 (88–99) | 93 (84–98) | 0.904 | 83 (72–91) | 87 (77–94) | 0.901 | 99 (92–100) | 97 (90–100) | > 0.999 | 97 (88–99) | 96 (88–99) | > 0.999 |
Grading agreement MRI versus surgery (ĸ) | 0.67 (0.51–0.83) | 0.56 (0.38–0.74) | - | 0.45 (0.26–0.64) | 0.60 (0.43–0.77) | - | 0.88 (0.73–1.00) | 0.89 (0.71–1.00) | - | 0.92 (0.80–1.00) | 0.86 (0.71–1.00) | - |
Interrater and intra-rater reliability
Parameter | GBCA-MRA κ value | 95% CI | Saline-MRA κ value | 95% CI |
---|---|---|---|---|
Intra-articular lesion | ||||
Labrum | 0.79 | 0.40–1.00 | 0.31 | –0.19–0.80 |
Acetabular cartilage | 0.66 | 0.47–0.85 | 0.77 | 0.61–0.93 |
Femoral cartilage | 0.94 | 0.84–1.00 | 0.87 | 0.70–1.00 |
Extensive cartilage damage | 0.78 | 0.60–0.80 | 0.96 | 0.79–1.00 |
Likert | ||||
Labrum | 0.60 | 0.63–0.84 | 0.55 | 0.33–0.78 |
Acetabular cartilage | 0.84 | 0.69–0.98 | 0.66 | 0.44–0.88 |
Femoral cartilage | 0.57 | 0.28–0.85 | 0.54 | 0.27–0.88 |
Ligamentum teres | 0.40 | 0.12–0.68 | 0.41 | 0.06–0.76 |
Capsule | 0.56 | 0.34–0.77 | 0.54 | 0.31–0.76 |
Overall contrast | 0.64 | 0.33–0.96 | 0.49 | 0.25–0.73 |
Parameter | GBCA-MRA κ value | 95% CI | Saline-MRA κ value | 95% CI |
---|---|---|---|---|
Intra-articular lesion | ||||
Labrum | 0.55 | 0.11–0.99 | 0.65 | 0.20–1.00 |
Acetabular cartilage | 0.71 | 0.54–0.89 | 0.73 | 0.56–0.90 |
Femoral cartilage | 0.83 | 0.65–1.00 | 0.77 | 0.55–0.99 |
Extensive cartilage damage | 0.81 | 0.64–0.99 | 0.82 | 0.66–0.99 |
Likert | ||||
Labrum | 0.89 | 0.73–1.00 | 0.88 | 0.75–1.00 |
Acetabular cartilage | 0.79 | 0.62–0.96 | 0.92 | 0.80– 1.00 |
Femoral cartilage | 0.79 | 0.50–1.00 | 0.78 | 0.54–1.00 |
Ligamentum teres | 0.84 | 0.67–1.00 | 0.82 | 0.57–1.00 |
Capsule | 0.79 | 0.62–0.95 | 0.79 | 0.61–0.97 |
Overall contrast | 0.93 | 0.78–1.00 | 0.77 | 0.25–1.00 |